In addition, it is also worthy to subject HMHA1 KO xenograft tumours to irradiation treatment and investigate whether abrogating HMHA1 can halt the HIF-dependent translocation of severely hypoxic cancer cells towards tumour blood vessels, and prevent tumour recurrence and distant metastases after irradiation. Here, ARHGAP45 is linked to cancer.